Patents Assigned to Geistlich Phama AG
  • Use of taurolidine to treat tumors
    Patent number: 7479505
    Abstract: The invention provides a method of inhibiting tumor growth in a mammal, by administering to the mammal composition containing taurolidine, taurultam, or a biologically active derivative thereof. The composition is administered to directly contact a tumor cell at a dose sufficient to induce cell death by apoptosis.
    Type: Grant
    Filed: March 8, 2004
    Date of Patent: January 20, 2009
    Assignee: Geistlich Phama AG
    Inventors: Paul Calabresi, James Darnowski